7.37
price up icon43.39%   2.23
after-market 시간 외 거래: 7.58 0.21 +2.85%
loading

Urogen Pharma Ltd 주식(URGN)의 최신 뉴스

pulisher
10:39 AM

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - GlobeNewswire

10:39 AM
pulisher
10:17 AM

ROSEN, LEADING INVESTOR COUNSEL, Encourages UroGen Pharma - GlobeNewswire

10:17 AM
pulisher
10:15 AM

ROSEN, LEADING INVESTOR COUNSEL, Encourages UroGen Pharma Ltd. Investors to Secure Counsel ... - Eagle-Tribune

10:15 AM
pulisher
08:41 AM

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing R - GuruFocus

08:41 AM
pulisher
08:00 AM

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

08:00 AM
pulisher
05:45 AM

Shareholders that lost money on UroGen Pharma Ltd.(URGN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire

05:45 AM
pulisher
Jun 05, 2025

Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Lost Money on UroGen Pharma Ltd. (URGN)? Urged to Join Class Action Before July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Shareholders who lost money on UroGen Pharma Ltd. (NASDAQ: URGN) Should Contact Wolf Haldenstein - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman - PR Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Shareholders that lost money on UroGen Pharma Ltd. (URGN) Urged to Join Class Action – Contact ... - Bluefield Daily Telegraph

Jun 05, 2025
pulisher
Jun 05, 2025

Shareholders that lost money on UroGen Pharma Ltd. (URGN) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Cuts Stock Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

The Gross Law Firm Notifies UroGen Pharma Ltd. Investors of a Class Action Lawsuit and Upcoming DeadlineURGN - PR Newswire

Jun 05, 2025
pulisher
Jun 04, 2025

Deadline Alert: UroGen Pharma Ltd. (URGN) Investors Who - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

Iovance’s (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit– Hagens Berman - GlobeNewswire Inc.

Jun 04, 2025
pulisher
Jun 04, 2025

UroGen Pharma Ltd. (URGN) Faces Securities Class Action - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - PR Newswire

Jun 04, 2025
pulisher
Jun 04, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Jane Street Group LLC Sells 4,380 Shares of UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

UroGen Pharma (NASDAQ:URGN) Price Target Cut to $10.00 by Analysts at Oppenheimer - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Rosen Law Firm Urges UroGen Pharma Ltd. (NASDAQ: URGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

UROGEN PHARMA LTD. (NASDAQ: URGN) INVESTOR ALERT: Investors - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Oppenheimer Lowers Price Target for UroGen Pharma (URGN) to $10.00 | URGN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oppenheimer Adjusts UroGen Pharma Price Target to $10 From $36, Maintains Outperform Rating - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

UroGen Pharma Ltd. (URGN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 28, 2025 Deadline - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

UroGen Pharma (URGN) Target Price Adjusted by Oppenheimer | URGN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oppenheimer lowers UroGen Pharma stock price target to $10 - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Makes New $137,000 Investment in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

URGN INVESTOR NOTICE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve

Jun 03, 2025
pulisher
Jun 03, 2025

UroGen Pharma Ltd. (URGN) Launches uTRACT Registry to Track JELMYTO Use in UTUC - Insider Monkey

Jun 03, 2025
pulisher
Jun 02, 2025

UROGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

URGN STOCK: Suffer Losses on UroGen Pharma Ltd.? BFA Law - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Deadline Approaching: UroGen Pharma Ltd. (URGN) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith - Business Wire

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Desi - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Designed to Study Real-World Use of JELMYTO in Low-Grade Upper Tract Urothelial Cancer - Business Wire

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen presents promising bladder cancer study results - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen presents promising bladder cancer study results By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) | URGN Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) - Business Wire

Jun 02, 2025
pulisher
Jun 02, 2025

URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Jun 02, 2025
pulisher
Jun 02, 2025

URGN INVESTOR NOTICE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

Jun 02, 2025
pulisher
Jun 01, 2025

Lost Money on UroGen Pharma Ltd. (URGN)? Join Class Action Before July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd.URGN - PR Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - StreetInsider

Jun 01, 2025
pulisher
Jun 01, 2025

Securities Lawsuit Alert: UroGen Pharma Ltd. (URGN) InvestorsContact Levi & Korsinsky Before July 28, 2025 - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

URGN CLASS ALERT: BFA Law Notifies UroGen Pharma Ltd. Investors to Contact the Firm before the July 28 Securities Fraud Class Action Deadline - Newsfile

Jun 01, 2025
pulisher
Jun 01, 2025

Deutsche Bank AG Has $333,000 Stake in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Class Action Lawsuit Filed: UroGen Pharma Ltd. (URGN)Join by July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 31, 2025
pulisher
May 31, 2025

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued - GlobeNewswire

May 31, 2025
pulisher
May 30, 2025

Levi & Korsinsky Investigates UroGen Pharma Ltd. (URGN) Over Possible Securities Fraud - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Pharma Co. Hid Cancer Study Method Problems, Investor Claims - Law360

May 30, 2025
pulisher
May 30, 2025

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - The Malaysian Reserve

May 30, 2025
pulisher
May 30, 2025

URGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

URGN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of UroGen Pharma Ltd. Investors - Business Wire

May 30, 2025
pulisher
May 30, 2025

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against UroGen Pharma Ltd. - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against ... - Eagle-Tribune

May 30, 2025
pulisher
May 30, 2025

Investigation Opened on Behalf of UroGen Pharma Ltd. (URGN) ShareholdersContact Levi & Korsinsky - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Fraud Investigation Opened: Levi & Korsinsky Investigates UroGen Pharma Ltd. (URGN) on Behalf of Shareholders - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Ongoing Securities Investigation into UroGen Pharma Ltd. (URGN)Contact Levi & Korsinsky - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Did UroGen Pharma Ltd. (URGN) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

URGN FRAUD ALERT: UroGen Pharma Ltd. Investors are Alerted to Contact BFA Law about the Pending Securities Fraud Class Action - Newsfile

May 30, 2025
pulisher
May 30, 2025

URGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 30, 2025
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.30%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
자본화:     |  볼륨(24시간):